)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Lunai Bioworks
Lunai Bioworks (LNAI) investor relations material
Lunai Bioworks Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary17 Feb, 2026
Executive summary
Achieved net income of $1.0 million for the six months ended December 31, 2025, compared to a net loss of $51.5 million in the prior year period, driven by a gain on subsidiary bankruptcy and reduced operating expenses.
Operating expenses decreased 91% year-over-year for the six months, primarily due to lower goodwill impairment, general and administrative, and R&D costs.
Completed the acquisition of BioSymetrics Inc., expanding AI-driven biomedical capabilities and segment reporting.
Deconsolidated Gedi Cube B.V. following its bankruptcy, resulting in a $12.0 million gain.
Financial highlights
Net income for the six months ended December 31, 2025, was $1.0 million, compared to a net loss of $51.5 million in the prior year period.
Operating expenses for the six months were $5.1 million, down from $57.9 million year-over-year, reflecting a $47.6 million decrease in goodwill impairment.
Cash at period end was $491,645, up from $92,700 at June 30, 2025; working capital deficit improved to $19.5 million from $28.1 million.
Total assets decreased to $6.7 million from $8.2 million at June 30, 2025; total liabilities decreased to $20.2 million from $29.6 million.
Net cash used in operating activities was $2.4 million for the six months, with $2.3 million provided by financing activities.
Outlook and guidance
Management continues to focus on AI-driven neurology and oncology diagnostics and therapeutics, with cost reductions and workforce streamlining.
Ongoing need for additional funding through equity or debt; substantial doubt exists about the ability to continue as a going concern.
Funding in fiscal 2026 is expected to support obligations, product commercialization, and clinical development.
Sustainability of 6M 2025 net income drivers
Impact of ongoing litigation on company financials
Nasdaq delisting appeal and funding strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Lunai Bioworks earnings date
Q3 202614 May, 2026
Lunai Bioworks
Next Lunai Bioworks earnings date
Q3 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Renovaro Inc. is a biotechnology company focused on developing advanced allogeneic cell and gene therapies. These therapies are designed to enhance immune system responses with the potential for long-term or life-long remission in some of the most challenging cancers, as well as the treatment or possible cure of serious infectious diseases, including HIV and Hepatitis B virus (HBV). The company leverages its proprietary platforms in gene and cell therapy to create therapeutic candidates aimed at hyper-stimulating the immune system to target and destroy cancer cells and virus-infected cells. Renovaro Inc. is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage